Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Pancreatic Ductal Adenocarcinoma
100%
Receptor-interacting Protein Kinase 1 (RIPK1)
100%
AAA+ ATPase
100%
Thyroid Hormone Receptor
100%
DCZ0415
54%
Immune Response
27%
Knockdown
27%
Gemcitabine
27%
Pancreatic Duct Cells
18%
Mouse Model
9%
Apoptosis
9%
Tumor Growth
9%
Infiltration
9%
Cancer Progression
9%
In Cancer
9%
Angiogenesis
9%
Syngeneic
9%
Pharmacologic
9%
Apoptosis Induction
9%
E-cadherin
9%
Tumor Metastasis
9%
Tumor Progression
9%
Programmed Death-ligand 1 (PD-L1)
9%
CD4 T Cells
9%
Immunodeficient Mice
9%
Mechanism of Action
9%
Granzyme B
9%
Colony Formation
9%
Functional Role
9%
Functional Mechanism
9%
Pancreatic Tissue
9%
Vimentin
9%
STAT3 Phosphorylation
9%
Malignant Phenotype
9%
Anticancer Effect
9%
N-cadherin
9%
Beta-catenin
9%
Fibroblast Growth Factor Receptor 4 (FGFR4)
9%
Antimetastatic
9%
Antitumorigenic Activity
9%
Tumor Immune
9%
G2/M Phase Cell Cycle Arrest
9%
Perforin Expression
9%
Biochemistry, Genetics and Molecular Biology
Carcinogenesis
100%
ATPase
100%
Thyroid Hormone Receptor
100%
Immune Response
27%
Gemcitabine
27%
Tumor Progression
18%
Programmed Cell Death
18%
Catenin
9%
Downregulation
9%
Mouse Model
9%
T Cell
9%
Cell Cycle Arrest
9%
Angiogenesis
9%
CD4
9%
Anticancer
9%
Syngenic
9%
Colony Formation
9%
Vimentin
9%
STAT3
9%
Neural Cell Adhesion Molecule
9%
Granzyme B
9%
Cell Cycle Checkpoint
9%
Perforin
9%
Carcinogenic Activity
9%
Fibroblast Growth Factor Receptor 4
9%
Cadherin
9%
PDAC
9%
phosphorylation
9%
Pharmacology, Toxicology and Pharmaceutical Science
Carcinogenesis
100%
Adenosine Triphosphatase
100%
Pancreas Adenocarcinoma
100%
Thyroid Hormone Receptor
100%
Gemcitabine
27%
Tumor Growth
18%
Mouse Model
9%
Cancer Growth
9%
Catenin
9%
Uvomorulin
9%
Nerve Cell Adhesion Molecule
9%
Vimentin
9%
Perforin
9%
Granzyme B
9%
CD3 Antigen
9%
Fibroblast Growth Factor Receptor 4
9%